AAV has been used to express a wide array of anti-cancer agents including endostatin [41,42], angiostatin [43,44], pigment epithelium-derived factor (PEDF) [45], and VEGF-Trap [46,47], to name a few. The gene discussed is VEGFA; the disease is cancer.